GCH1 mutation and clinical study of Chinese patients with dopa-responsive dystonia

Movement Disorders

Volumn 25, Issue 4, 2010, Pages 447-451

  Liu, Xin ^a   Zhang, Shu Shan ^a   Fang, Deng Fu ^a   Ma, Ming Yi ^a   Guo, Xiao Yan ^a   Yang, Yuan ^a   Shang, Hui Fang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Clinical feature; Dopa responsive dystonia; GCH1 gene

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; TRIHEXYPHENIDYL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; DOPA RESPONSIVE DYSKINESIA; DOPA RESPONSIVE DYSTONIA; DRUG MEGADOSE; DYSKINESIA; DYSTONIA; EXON; FEMALE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PEDIGREE; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCOLIOSIS; SIDE EFFECT; TREATMENT RESPONSE; WALKING DIFFICULTY;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DOPAMINE AGONISTS; DYSTONIA; EXONS; FEMALE; GTP CYCLOHYDROLASE; HUMANS; INFANT; LEVODOPA; MALE; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77949529930     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22976     Document Type: Article

References (27)

1. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976;14:215-233.
2. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol 1988;50:377-384.
3. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69.
4. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996;5:403-406.
5. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature genetics 1994;8:236-242.
6. Kaufman S. Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. J Biol Chem 1959;234:2677-2682.
7. Zhang S, Zheng H, Xie H, Ren D. Molecular genetics of dopa-responsive dystonia in Chinese. Acad J Sec Mil Med Univ 2002;23:1223-1226.
8. Zhou HY, Zhang BS. The mutations in GTP-cyclohydrolase I gene in Chinese patients with dopa responsive dystonia. Chin J Neurol 2005;38:42-45.
9. Xie H, Wu ZY, N. W, Li ZW, Lin MT, Murong SX. Clinical analysis of dopa-responsive dystonia and mutation analysis of the GCH I gene. Zhonghua Er Ke Za Zhi 2006;44:492-495.
10. Li J, Tang BS, Guo JF, et al. Mutation analysis of GCH1 gene in Chinese patients with dopa responsive dystonia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007;24:302-304.
11. Wu ZY, Lin Y, Chen WJ, et al. Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families. Clin Genet 2008;74:513-552.
12. Shang H, Clerc N, Lang D, Kaelin-Lang A, Burgunder JM. Clinical and molecular genetic evaluation of patients with primary dystonia. Eur J Neurol 2005;12:131-138.
13. Nygaard TG. Dopa-responsive dystonia. Curr Opin Neurol 1995;8:310-313.
14. Segawa M. Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med J 2009;32:1-11.
15. Nygaard TG, Wooten GF. Dopa-responsive dystonia: some pieces of the puzzle are still missing. Neurology 1998;50:853-855.
16. Chen RS, Huang CC, Lu CS. Dopa-responsive dystonia: clinical and family study in Taiwanese. Clin Neurol Neurosurg 1996;98:43-46.
17. Hwang WJ, Calne DB, Tsui JK, de la Fuente-Fernandez R. The long-term response to levodopa in dopa-responsive dystonia. Parkinsonism Relat Disord 2001;8:1-5.
18. Jarman PR, Bandmann O, Marsden CD, Wood NW. GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs. J Neurol Neurosurg Psychiatry 1997;63:304-308.
19. Bandmann O, Valente EM, Holmans P, et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Annals of Neurology 1998;44:649-656.
20. Steinberger D, Korinthenberg R, Topka H, Berghauser M, Wedde R, Muller U. Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa.German Dystonia Study Group. Neurology 2000;55:1735-1737.
21. Furukawa Y. Update on dopa-responsive dystonia: locus heterogeneity and biochemical features. Adv Neurol 2004;94:127-138.
22. Zirn B, Steinberger D, Troidl C, et al. Frequency of GCH1 deletions in Dopa-responsive dystonia. J Neurol Neurosurg Psychiatry 2008;79:183-186.
23. Furukawa Y, Guttman M, Sparagana SP, et al. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol 2000;47:517-520.
24. Klein C, Hedrich K, Kabakci K, et al. Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia. Neurology 2002;59:1783-1786.
25. Hagenah J, Saunders-Pullman R, Hedrich K, et al. High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology 2005;64:908-911.
26. Steinberger D, Trubenbach J, Zirn B, Leube B, Wildhardt G, Muller U. Utility of MLPA in deletion analysis of GCH1 in dopa-responsive dystonia. Neurogenetics 2007;8:51-55.
27. Wider C, Melquist S, Hauf M, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008;70 (16 Pt 2):1377-1383.